Is Idexx Laboratories (IDXX) overvalued or fairly valued?

MarketChacha shows Idexx Laboratories's valuation in context — a forward P/E of about 33.1, a price-to-book of about 27.9 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Idexx Laboratories (IDXX)?

Idexx Laboratories last traded at $547.07 (-1.0% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Idexx Laboratories

IDXX · NASDAQ · Healthcare · United States

$547.07-1.0%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:40 PM

Snapshot

TickerIDXX

ExchangeNASDAQ

SectorHealthcare

IndustryDiagnostics & Research

CountryUnited States

Employees11,000

HeadquartersWestbrook, United States

Market cap$43.2B

P/B27.9

Volume123.84K

Websitewww.idexx.com

Filings tracked0

About Idexx Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.2%
Institutions98.2%
Public & other1.5%

1,841 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.10.61%
Vanguard Capital Management LLC6.57%
Vanguard Portfolio Management LLC4.96%
State Street Corporation4.66%
Invesco Ltd.4.25%
Geode Capital Management, LLC3.37%
BAMCO Inc.2.07%
Bank Of New York Mellon Corporation1.91%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $1.2B · EPS 3.78

Est. earnings growth +11.3%

Next fiscal year

Rev $5.1B · EPS 16.52

Est. earnings growth +13.0%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$518.5552-wk range$769.98

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about IDXX

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.